Naeun Lee Selected Research

Naeun Lee Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 03/2011
4	Infections 01/2017 - 06/2012
4	Glaucoma 04/2015 - 04/2014
3	Inflammation (Inflammations) 09/2014 - 07/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 11/2017
2	Insulin Resistance 07/2021 - 01/2020
2	Melanoma (Melanoma, Malignant) 10/2020 - 03/2011
1	Mouth Neoplasms (Oral Cancer) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Experimental Melanoma 10/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Arthritis (Polyarthritis) 04/2017
1	Ischemia 06/2016
1	Optic Nerve Injuries 06/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2016
1	Obesity 06/2016
1	Endophthalmitis (Ophthalmia) 04/2015
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2015
1	Meibomian Gland Dysfunction 01/2015
1	Hyperemia 01/2015
1	Asthma (Bronchial Asthma) 12/2014
1	Virus Diseases (Viral Diseases) 02/2013
1	Osteoarthritis 07/2012
1	Rheumatoid Arthritis 07/2012
1	Autoimmune Diseases (Autoimmune Disease) 05/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2012
1	Hemolysis 05/2008

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 10/2020 - 02/2013
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	pitavastatin (itavastatin)FDA Link 01/2022 - 01/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
2	LipidsIBA 01/2022 - 01/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2021 - 11/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 06/2016
2	Interleukin-6 (Interleukin 6)IBA 06/2016 - 12/2014
2	Ophthalmic Solutions (Eye Drops)IBA 01/2015 - 04/2014
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2013 - 03/2011
1	Histone Deacetylase 6IBA 12/2021
1	citarinostatIBA 12/2021
1	Insulin (Novolin)FDA Link 07/2021
1	Triglycerides (Triacylglycerol)IBA 07/2021
1	Interferon-gamma (Interferon, gamma)IBA 10/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2020
1	SestrinsIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 09/2019
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 11/2017
1	Antirheumatic Agents (DMARD)IBA 04/2017
1	BerberineIBA 04/2017
1	Methotrexate (Mexate)FDA LinkGeneric 04/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Neuroprotective AgentsIBA 06/2016
1	Retinaldehyde (Retinal)IBA 06/2016
1	Etanercept (Enbrel)FDA Link 06/2016
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2015
1	Interleukin-13IBA 12/2014
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2014
1	SuperantigensIBA 12/2014
1	Interleukin-5 (Interleukin 5)IBA 12/2014
1	Silicon Dioxide (Silica)FDA LinkGeneric 09/2014
1	Interleukin-15 (Interleukin 15)IBA 05/2014
1	Antiglaucoma AgentsIBA 04/2014
1	InterferonsIBA 04/2013
1	Biological ProductsIBA 02/2013
1	Peptides (Polypeptides)IBA 02/2013
1	Interleukin-27 (Interleukin 27)IBA 02/2013
1	p38 Mitogen-Activated Protein KinasesIBA 07/2012
1	Prostaglandins EIBA 07/2012
1	Phosphopyruvate Hydratase (Enolase)IBA 07/2012
1	Interleukin-1 (Interleukin 1)IBA 07/2012
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 06/2012
1	RNA (Ribonucleic Acid)IBA 05/2012
1	InflammasomesIBA 05/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2011
1	rhamnolipidIBA 05/2008

Therapy/Procedure

1	Immunotherapy 10/2020
1	Trabeculectomy (Trabeculoplasty) 04/2015
1	Lasers (Laser) 04/2015